The JUPITER Study — Is the News as Encouraging as It Seems?

Every major news wire service was abuzz this past week over Crestor. The study released November 9 involved 18,000 patients, and supplied powerful evidence that statins save lives by driving down blood cholesterol and reducing inflammation in arteries as measured by high blood levels of C-reactive protein. In the study published in the New England Journal… Continue reading The JUPITER Study — Is the News as Encouraging as It Seems?

What Effects Will the Pending FDA Regulation Changes Have on Stevia and Other Substances?

The FDA is currently receiving comment about Section 912 of its Amendments Act (FDAAA), which deals with the regulation of foods containing substances that have undergone clinical trials; they have now extended that comment period until November 25. The Section 912 regulations could create a major shift in the divide between foods and drugs.

Decision on BPA—Is the FDA Conclusion Deeply Flawed?

The topic of bisphenol A (BPA) regulation has been discussed in the September 9 and September 23 issues of Pulse of Health Freedom. Now thirty-six scientific advisers on an independent panel have concluded that the draft decision of the FDA on BPA used “unacceptable criteria for selecting data and depend(ed) heavily upon a key paper… Continue reading Decision on BPA—Is the FDA Conclusion Deeply Flawed?